nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMPR2—pulmonary artery—thymus cancer	0.0233	0.043	CbGeAlD
Ruxolitinib—RET—parathyroid gland—thymus cancer	0.0121	0.0223	CbGeAlD
Ruxolitinib—Herpes zoster—Octreotide—thymus cancer	0.01	0.117	CcSEcCtD
Ruxolitinib—Contusion—Octreotide—thymus cancer	0.00864	0.101	CcSEcCtD
Ruxolitinib—PLK1—hematopoietic system—thymus cancer	0.00669	0.0123	CbGeAlD
Ruxolitinib—DCLK3—hematopoietic system—thymus cancer	0.00635	0.0117	CbGeAlD
Ruxolitinib—JAK1—neck—thymus cancer	0.00576	0.0106	CbGeAlD
Ruxolitinib—PRKG2—pituitary gland—thymus cancer	0.00554	0.0102	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00547	0.0638	CcSEcCtD
Ruxolitinib—CAMK1—hematopoietic system—thymus cancer	0.00523	0.00963	CbGeAlD
Ruxolitinib—MARK2—hematopoietic system—thymus cancer	0.00507	0.00935	CbGeAlD
Ruxolitinib—RPS6KA6—pituitary gland—thymus cancer	0.00497	0.00915	CbGeAlD
Ruxolitinib—MAST1—pituitary gland—thymus cancer	0.00497	0.00915	CbGeAlD
Ruxolitinib—PLK1—lymphoid tissue—thymus cancer	0.00471	0.00868	CbGeAlD
Ruxolitinib—DCLK3—pituitary gland—thymus cancer	0.00471	0.00867	CbGeAlD
Ruxolitinib—PRKCE—thyroid gland—thymus cancer	0.00446	0.00821	CbGeAlD
Ruxolitinib—PRKG2—lung—thymus cancer	0.00433	0.00799	CbGeAlD
Ruxolitinib—JAK3—hematopoietic system—thymus cancer	0.00431	0.00795	CbGeAlD
Ruxolitinib—BMP2K—neck—thymus cancer	0.00431	0.00794	CbGeAlD
Ruxolitinib—Weight increased—Octreotide—thymus cancer	0.0043	0.0502	CcSEcCtD
Ruxolitinib—JAK1—hematopoietic system—thymus cancer	0.00429	0.0079	CbGeAlD
Ruxolitinib—RPS6KA6—thyroid gland—thymus cancer	0.00428	0.00789	CbGeAlD
Ruxolitinib—Weight decreased—Octreotide—thymus cancer	0.00428	0.0499	CcSEcCtD
Ruxolitinib—PLK4—hematopoietic system—thymus cancer	0.00426	0.00785	CbGeAlD
Ruxolitinib—PLK3—cardiac atrium—thymus cancer	0.00424	0.00782	CbGeAlD
Ruxolitinib—PLK3—pituitary gland—thymus cancer	0.00414	0.00764	CbGeAlD
Ruxolitinib—Urinary tract infection—Octreotide—thymus cancer	0.0041	0.0478	CcSEcCtD
Ruxolitinib—PRKCE—lung—thymus cancer	0.00405	0.00746	CbGeAlD
Ruxolitinib—STK16—hematopoietic system—thymus cancer	0.00402	0.00741	CbGeAlD
Ruxolitinib—Haematuria—Octreotide—thymus cancer	0.00402	0.0469	CcSEcCtD
Ruxolitinib—HIPK2—hematopoietic system—thymus cancer	0.004	0.00737	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Octreotide—thymus cancer	0.00399	0.0465	CcSEcCtD
Ruxolitinib—Epistaxis—Octreotide—thymus cancer	0.00398	0.0464	CcSEcCtD
Ruxolitinib—JAK1—epithelium—thymus cancer	0.00392	0.00722	CbGeAlD
Ruxolitinib—PLK1—lung—thymus cancer	0.00389	0.00716	CbGeAlD
Ruxolitinib—RPS6KA6—lung—thymus cancer	0.00389	0.00716	CbGeAlD
Ruxolitinib—CAMK1—pituitary gland—thymus cancer	0.00388	0.00714	CbGeAlD
Ruxolitinib—ROCK1—hematopoietic system—thymus cancer	0.00369	0.0068	CbGeAlD
Ruxolitinib—RET—neck—thymus cancer	0.00367	0.00675	CbGeAlD
Ruxolitinib—DYRK1A—hematopoietic system—thymus cancer	0.0036	0.00663	CbGeAlD
Ruxolitinib—BMPR2—hematopoietic system—thymus cancer	0.00359	0.00661	CbGeAlD
Ruxolitinib—PLK3—thyroid gland—thymus cancer	0.00357	0.00658	CbGeAlD
Ruxolitinib—TAOK2—pituitary gland—thymus cancer	0.00348	0.00642	CbGeAlD
Ruxolitinib—ROCK1—epithelium—thymus cancer	0.00337	0.00622	CbGeAlD
Ruxolitinib—CAMK1—thyroid gland—thymus cancer	0.00334	0.00616	CbGeAlD
Ruxolitinib—Malnutrition—Octreotide—thymus cancer	0.0033	0.0384	CcSEcCtD
Ruxolitinib—JAK1—cardiac atrium—thymus cancer	0.00325	0.006	CbGeAlD
Ruxolitinib—Flatulence—Octreotide—thymus cancer	0.00325	0.0379	CcSEcCtD
Ruxolitinib—PLK3—lung—thymus cancer	0.00324	0.00598	CbGeAlD
Ruxolitinib—MARK2—thyroid gland—thymus cancer	0.00324	0.00598	CbGeAlD
Ruxolitinib—LRRK2—hematopoietic system—thymus cancer	0.00318	0.00586	CbGeAlD
Ruxolitinib—DCLK1—pituitary gland—thymus cancer	0.00318	0.00586	CbGeAlD
Ruxolitinib—JAK1—pituitary gland—thymus cancer	0.00318	0.00586	CbGeAlD
Ruxolitinib—CAMK1D—cardiac atrium—thymus cancer	0.00318	0.00585	CbGeAlD
Ruxolitinib—LTK—lung—thymus cancer	0.00313	0.00577	CbGeAlD
Ruxolitinib—DAPK2—cardiac atrium—thymus cancer	0.0031	0.00572	CbGeAlD
Ruxolitinib—CAMK1D—pituitary gland—thymus cancer	0.0031	0.00572	CbGeAlD
Ruxolitinib—Anaemia—Octreotide—thymus cancer	0.00305	0.0355	CcSEcCtD
Ruxolitinib—JAK3—lymphoid tissue—thymus cancer	0.00304	0.0056	CbGeAlD
Ruxolitinib—CAMK1—lung—thymus cancer	0.00303	0.00559	CbGeAlD
Ruxolitinib—JAK1—lymphoid tissue—thymus cancer	0.00302	0.00556	CbGeAlD
Ruxolitinib—TAOK2—thyroid gland—thymus cancer	0.003	0.00553	CbGeAlD
Ruxolitinib—PLK4—lymphoid tissue—thymus cancer	0.003	0.00553	CbGeAlD
Ruxolitinib—STK16—pituitary gland—thymus cancer	0.00298	0.0055	CbGeAlD
Ruxolitinib—MARK2—lung—thymus cancer	0.00295	0.00543	CbGeAlD
Ruxolitinib—DAPK3—cardiac atrium—thymus cancer	0.00292	0.00538	CbGeAlD
Ruxolitinib—MAP3K2—hematopoietic system—thymus cancer	0.00291	0.00537	CbGeAlD
Ruxolitinib—CLK2—cardiac atrium—thymus cancer	0.00289	0.00533	CbGeAlD
Ruxolitinib—DAPK3—pituitary gland—thymus cancer	0.00285	0.00525	CbGeAlD
Ruxolitinib—TYK2—hematopoietic system—thymus cancer	0.00283	0.00522	CbGeAlD
Ruxolitinib—STK16—lymphoid tissue—thymus cancer	0.00283	0.00522	CbGeAlD
Ruxolitinib—CLK2—pituitary gland—thymus cancer	0.00283	0.00521	CbGeAlD
Ruxolitinib—HIPK2—lymphoid tissue—thymus cancer	0.00282	0.00519	CbGeAlD
Ruxolitinib—MKNK2—hematopoietic system—thymus cancer	0.0028	0.00515	CbGeAlD
Ruxolitinib—IRAK1—hematopoietic system—thymus cancer	0.0028	0.00515	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00279	0.0325	CcSEcCtD
Ruxolitinib—PRKCE—lymph node—thymus cancer	0.00277	0.0051	CbGeAlD
Ruxolitinib—JAK3—thyroid gland—thymus cancer	0.00276	0.00508	CbGeAlD
Ruxolitinib—JAK1—bone marrow—thymus cancer	0.00275	0.00506	CbGeAlD
Ruxolitinib—JAK1—thyroid gland—thymus cancer	0.00274	0.00505	CbGeAlD
Ruxolitinib—DCLK1—thyroid gland—thymus cancer	0.00274	0.00505	CbGeAlD
Ruxolitinib—PLK4—bone marrow—thymus cancer	0.00273	0.00503	CbGeAlD
Ruxolitinib—RET—hematopoietic system—thymus cancer	0.00273	0.00503	CbGeAlD
Ruxolitinib—TAOK2—lung—thymus cancer	0.00273	0.00502	CbGeAlD
Ruxolitinib—BMPR2—cardiac atrium—thymus cancer	0.00272	0.00502	CbGeAlD
Ruxolitinib—CLK2—lymphoid tissue—thymus cancer	0.00268	0.00494	CbGeAlD
Ruxolitinib—CAMK1D—thyroid gland—thymus cancer	0.00268	0.00493	CbGeAlD
Ruxolitinib—Infection—Octreotide—thymus cancer	0.00267	0.0311	CcSEcCtD
Ruxolitinib—BMPR2—pituitary gland—thymus cancer	0.00266	0.0049	CbGeAlD
Ruxolitinib—PHKG2—thyroid gland—thymus cancer	0.00266	0.0049	CbGeAlD
Ruxolitinib—RPS6KA6—lymph node—thymus cancer	0.00266	0.0049	CbGeAlD
Ruxolitinib—PLK1—lymph node—thymus cancer	0.00266	0.0049	CbGeAlD
Ruxolitinib—Nervous system disorder—Octreotide—thymus cancer	0.00264	0.0307	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Octreotide—thymus cancer	0.00263	0.0307	CcSEcCtD
Ruxolitinib—DAPK2—bone marrow—thymus cancer	0.00262	0.00483	CbGeAlD
Ruxolitinib—DAPK2—thyroid gland—thymus cancer	0.00261	0.00482	CbGeAlD
Ruxolitinib—Skin disorder—Octreotide—thymus cancer	0.00261	0.0305	CcSEcCtD
Ruxolitinib—ROCK1—lymphoid tissue—thymus cancer	0.0026	0.00479	CbGeAlD
Ruxolitinib—JAK2—hematopoietic system—thymus cancer	0.00258	0.00475	CbGeAlD
Ruxolitinib—STK16—thyroid gland—thymus cancer	0.00257	0.00474	CbGeAlD
Ruxolitinib—HIPK2—thyroid gland—thymus cancer	0.00256	0.00471	CbGeAlD
Ruxolitinib—MKNK2—epithelium—thymus cancer	0.00256	0.00471	CbGeAlD
Ruxolitinib—NUAK2—pituitary gland—thymus cancer	0.00254	0.00468	CbGeAlD
Ruxolitinib—DYRK1A—lymphoid tissue—thymus cancer	0.00253	0.00467	CbGeAlD
Ruxolitinib—BMPR2—lymphoid tissue—thymus cancer	0.00252	0.00465	CbGeAlD
Ruxolitinib—JAK3—lung—thymus cancer	0.00251	0.00462	CbGeAlD
Ruxolitinib—RET—epithelium—thymus cancer	0.00249	0.00459	CbGeAlD
Ruxolitinib—DCLK1—lung—thymus cancer	0.00249	0.00459	CbGeAlD
Ruxolitinib—JAK1—lung—thymus cancer	0.00249	0.00459	CbGeAlD
Ruxolitinib—MAP3K3—hematopoietic system—thymus cancer	0.00249	0.00458	CbGeAlD
Ruxolitinib—PLK4—lung—thymus cancer	0.00247	0.00456	CbGeAlD
Ruxolitinib—DAPK3—thyroid gland—thymus cancer	0.00246	0.00453	CbGeAlD
Ruxolitinib—CLK2—bone marrow—thymus cancer	0.00244	0.0045	CbGeAlD
Ruxolitinib—CLK2—thyroid gland—thymus cancer	0.00244	0.00449	CbGeAlD
Ruxolitinib—CAMK1D—lung—thymus cancer	0.00243	0.00448	CbGeAlD
Ruxolitinib—PHKG2—lung—thymus cancer	0.00242	0.00445	CbGeAlD
Ruxolitinib—CAMK2G—pituitary gland—thymus cancer	0.00238	0.00439	CbGeAlD
Ruxolitinib—DAPK2—lung—thymus cancer	0.00237	0.00438	CbGeAlD
Ruxolitinib—LRRK2—pituitary gland—thymus cancer	0.00236	0.00435	CbGeAlD
Ruxolitinib—JAK2—epithelium—thymus cancer	0.00236	0.00434	CbGeAlD
Ruxolitinib—STK16—lung—thymus cancer	0.00234	0.0043	CbGeAlD
Ruxolitinib—HIPK2—lung—thymus cancer	0.00232	0.00428	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Octreotide—thymus cancer	0.00232	0.0271	CcSEcCtD
Ruxolitinib—Fatigue—Octreotide—thymus cancer	0.00232	0.027	CcSEcCtD
Ruxolitinib—DYRK1A—thyroid gland—thymus cancer	0.0023	0.00424	CbGeAlD
Ruxolitinib—BMPR2—thyroid gland—thymus cancer	0.00229	0.00422	CbGeAlD
Ruxolitinib—MAP3K19—lung—thymus cancer	0.00228	0.0042	CbGeAlD
Ruxolitinib—TAOK3—hematopoietic system—thymus cancer	0.00227	0.00417	CbGeAlD
Ruxolitinib—DAPK3—lung—thymus cancer	0.00223	0.00411	CbGeAlD
Ruxolitinib—PLK3—lymph node—thymus cancer	0.00222	0.00409	CbGeAlD
Ruxolitinib—CLK2—lung—thymus cancer	0.00221	0.00408	CbGeAlD
Ruxolitinib—NUAK2—bone marrow—thymus cancer	0.0022	0.00405	CbGeAlD
Ruxolitinib—MAP3K7—cardiac atrium—thymus cancer	0.00219	0.00404	CbGeAlD
Ruxolitinib—NUAK2—thyroid gland—thymus cancer	0.00219	0.00404	CbGeAlD
Ruxolitinib—TYK2—cardiac atrium—thymus cancer	0.00215	0.00397	CbGeAlD
Ruxolitinib—ROCK1—lung—thymus cancer	0.00214	0.00395	CbGeAlD
Ruxolitinib—LTK—lymph node—thymus cancer	0.00214	0.00395	CbGeAlD
Ruxolitinib—MAP3K7—pituitary gland—thymus cancer	0.00214	0.00394	CbGeAlD
Ruxolitinib—Body temperature increased—Octreotide—thymus cancer	0.00213	0.0248	CcSEcCtD
Ruxolitinib—MKNK2—cardiac atrium—thymus cancer	0.00212	0.00391	CbGeAlD
Ruxolitinib—TYK2—pituitary gland—thymus cancer	0.0021	0.00387	CbGeAlD
Ruxolitinib—DYRK1A—lung—thymus cancer	0.00209	0.00385	CbGeAlD
Ruxolitinib—BMPR2—lung—thymus cancer	0.00208	0.00384	CbGeAlD
Ruxolitinib—CAMK1—lymph node—thymus cancer	0.00208	0.00382	CbGeAlD
Ruxolitinib—MKNK2—pituitary gland—thymus cancer	0.00207	0.00382	CbGeAlD
Ruxolitinib—CAMK2G—bone marrow—thymus cancer	0.00206	0.00379	CbGeAlD
Ruxolitinib—BMP2K—bone marrow—thymus cancer	0.00206	0.00379	CbGeAlD
Ruxolitinib—CAMK2G—thyroid gland—thymus cancer	0.00205	0.00378	CbGeAlD
Ruxolitinib—BMP2K—thyroid gland—thymus cancer	0.00205	0.00378	CbGeAlD
Ruxolitinib—MAP3K2—lymphoid tissue—thymus cancer	0.00205	0.00378	CbGeAlD
Ruxolitinib—LRRK2—bone marrow—thymus cancer	0.00204	0.00376	CbGeAlD
Ruxolitinib—LRRK2—thyroid gland—thymus cancer	0.00203	0.00375	CbGeAlD
Ruxolitinib—RET—pituitary gland—thymus cancer	0.00202	0.00373	CbGeAlD
Ruxolitinib—MARK2—lymph node—thymus cancer	0.00202	0.00371	CbGeAlD
Ruxolitinib—TYK2—lymphoid tissue—thymus cancer	0.002	0.00368	CbGeAlD
Ruxolitinib—NUAK2—lung—thymus cancer	0.00199	0.00367	CbGeAlD
Ruxolitinib—MKNK2—lymphoid tissue—thymus cancer	0.00197	0.00363	CbGeAlD
Ruxolitinib—JAK2—cardiac atrium—thymus cancer	0.00196	0.00361	CbGeAlD
Ruxolitinib—Asthenia—Octreotide—thymus cancer	0.00193	0.0225	CcSEcCtD
Ruxolitinib—RET—lymphoid tissue—thymus cancer	0.00192	0.00354	CbGeAlD
Ruxolitinib—JAK2—pituitary gland—thymus cancer	0.00191	0.00352	CbGeAlD
Ruxolitinib—Pruritus—Octreotide—thymus cancer	0.0019	0.0222	CcSEcCtD
Ruxolitinib—MAP3K3—cardiac atrium—thymus cancer	0.00189	0.00348	CbGeAlD
Ruxolitinib—MAP3K2—bone marrow—thymus cancer	0.00187	0.00344	CbGeAlD
Ruxolitinib—TAOK2—lymph node—thymus cancer	0.00186	0.00344	CbGeAlD
Ruxolitinib—CAMK2G—lung—thymus cancer	0.00186	0.00343	CbGeAlD
Ruxolitinib—BMP2K—lung—thymus cancer	0.00186	0.00343	CbGeAlD
Ruxolitinib—MAP3K2—thyroid gland—thymus cancer	0.00186	0.00343	CbGeAlD
Ruxolitinib—MAP3K7—bone marrow—thymus cancer	0.00185	0.00341	CbGeAlD
Ruxolitinib—LRRK2—lung—thymus cancer	0.00185	0.0034	CbGeAlD
Ruxolitinib—MAP3K7—thyroid gland—thymus cancer	0.00185	0.0034	CbGeAlD
Ruxolitinib—MAP3K3—pituitary gland—thymus cancer	0.00184	0.0034	CbGeAlD
Ruxolitinib—TYK2—bone marrow—thymus cancer	0.00182	0.00335	CbGeAlD
Ruxolitinib—JAK2—lymphoid tissue—thymus cancer	0.00182	0.00334	CbGeAlD
Ruxolitinib—TYK2—thyroid gland—thymus cancer	0.00181	0.00334	CbGeAlD
Ruxolitinib—MKNK2—bone marrow—thymus cancer	0.00179	0.0033	CbGeAlD
Ruxolitinib—IRAK1—bone marrow—thymus cancer	0.00179	0.0033	CbGeAlD
Ruxolitinib—MKNK2—thyroid gland—thymus cancer	0.00179	0.0033	CbGeAlD
Ruxolitinib—IRAK1—thyroid gland—thymus cancer	0.00179	0.0033	CbGeAlD
Ruxolitinib—Dizziness—Octreotide—thymus cancer	0.00178	0.0207	CcSEcCtD
Ruxolitinib—RET—thyroid gland—thymus cancer	0.00174	0.00321	CbGeAlD
Ruxolitinib—TAOK3—cardiac atrium—thymus cancer	0.00172	0.00317	CbGeAlD
Ruxolitinib—JAK3—lymph node—thymus cancer	0.00171	0.00316	CbGeAlD
Ruxolitinib—JAK1—lymph node—thymus cancer	0.0017	0.00314	CbGeAlD
Ruxolitinib—DCLK1—lymph node—thymus cancer	0.0017	0.00314	CbGeAlD
Ruxolitinib—MAP3K2—lung—thymus cancer	0.00169	0.00312	CbGeAlD
Ruxolitinib—PLK4—lymph node—thymus cancer	0.00169	0.00312	CbGeAlD
Ruxolitinib—Headache—Octreotide—thymus cancer	0.00168	0.0196	CcSEcCtD
Ruxolitinib—TAOK3—pituitary gland—thymus cancer	0.00168	0.0031	CbGeAlD
Ruxolitinib—MAP3K7—lung—thymus cancer	0.00168	0.00309	CbGeAlD
Ruxolitinib—CAMK1D—lymph node—thymus cancer	0.00166	0.00306	CbGeAlD
Ruxolitinib—JAK2—bone marrow—thymus cancer	0.00165	0.00305	CbGeAlD
Ruxolitinib—PHKG2—lymph node—thymus cancer	0.00165	0.00304	CbGeAlD
Ruxolitinib—JAK2—thyroid gland—thymus cancer	0.00165	0.00304	CbGeAlD
Ruxolitinib—TYK2—lung—thymus cancer	0.00165	0.00303	CbGeAlD
Ruxolitinib—IRAK1—lung—thymus cancer	0.00162	0.00299	CbGeAlD
Ruxolitinib—MKNK2—lung—thymus cancer	0.00162	0.00299	CbGeAlD
Ruxolitinib—DAPK2—lymph node—thymus cancer	0.00162	0.00299	CbGeAlD
Ruxolitinib—STK16—lymph node—thymus cancer	0.0016	0.00294	CbGeAlD
Ruxolitinib—TAOK3—lymphoid tissue—thymus cancer	0.0016	0.00294	CbGeAlD
Ruxolitinib—MAP3K3—bone marrow—thymus cancer	0.00159	0.00294	CbGeAlD
Ruxolitinib—HIPK2—lymph node—thymus cancer	0.00159	0.00293	CbGeAlD
Ruxolitinib—MAP3K3—thyroid gland—thymus cancer	0.00159	0.00293	CbGeAlD
Ruxolitinib—DAPK3—lymph node—thymus cancer	0.00153	0.00281	CbGeAlD
Ruxolitinib—CLK2—lymph node—thymus cancer	0.00151	0.00279	CbGeAlD
Ruxolitinib—JAK2—lung—thymus cancer	0.0015	0.00276	CbGeAlD
Ruxolitinib—TAOK3—bone marrow—thymus cancer	0.00145	0.00268	CbGeAlD
Ruxolitinib—TAOK3—thyroid gland—thymus cancer	0.00145	0.00267	CbGeAlD
Ruxolitinib—MAP3K3—lung—thymus cancer	0.00144	0.00266	CbGeAlD
Ruxolitinib—DYRK1A—lymph node—thymus cancer	0.00143	0.00263	CbGeAlD
Ruxolitinib—BMPR2—lymph node—thymus cancer	0.00142	0.00262	CbGeAlD
Ruxolitinib—NUAK2—lymph node—thymus cancer	0.00136	0.00251	CbGeAlD
Ruxolitinib—TAOK3—lung—thymus cancer	0.00132	0.00242	CbGeAlD
Ruxolitinib—BMP2K—lymph node—thymus cancer	0.00127	0.00235	CbGeAlD
Ruxolitinib—CAMK2G—lymph node—thymus cancer	0.00127	0.00235	CbGeAlD
Ruxolitinib—LRRK2—lymph node—thymus cancer	0.00126	0.00233	CbGeAlD
Ruxolitinib—MAP3K2—lymph node—thymus cancer	0.00116	0.00213	CbGeAlD
Ruxolitinib—MAP3K7—lymph node—thymus cancer	0.00115	0.00211	CbGeAlD
Ruxolitinib—TYK2—lymph node—thymus cancer	0.00113	0.00207	CbGeAlD
Ruxolitinib—MKNK2—lymph node—thymus cancer	0.00111	0.00205	CbGeAlD
Ruxolitinib—IRAK1—lymph node—thymus cancer	0.00111	0.00205	CbGeAlD
Ruxolitinib—RET—lymph node—thymus cancer	0.00108	0.002	CbGeAlD
Ruxolitinib—JAK2—lymph node—thymus cancer	0.00102	0.00189	CbGeAlD
Ruxolitinib—MAP3K3—lymph node—thymus cancer	0.000987	0.00182	CbGeAlD
Ruxolitinib—TAOK3—lymph node—thymus cancer	0.0009	0.00166	CbGeAlD
Ruxolitinib—CYP3A4—hematopoietic system—thymus cancer	0.000688	0.00127	CbGeAlD
Ruxolitinib—JAK1—Signaling by ERBB2—AKT1—thymus cancer	0.000211	0.000569	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—AKT1—thymus cancer	0.00021	0.000566	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 signaling—AKT1—thymus cancer	0.00021	0.000566	CbGpPWpGaD
Ruxolitinib—ROCK1—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000209	0.000562	CbGpPWpGaD
Ruxolitinib—MAP3K7—DNA Damage Response (only ATM dependent)—AKT1—thymus cancer	0.000209	0.000562	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by VEGF—AKT1—thymus cancer	0.000206	0.000555	CbGpPWpGaD
Ruxolitinib—DYRK1A—Cell Cycle—TP53—thymus cancer	0.000202	0.000545	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—KIT—thymus cancer	0.000201	0.000542	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—AKT1—thymus cancer	0.000201	0.000541	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR in disease—AKT1—thymus cancer	0.000198	0.000532	CbGpPWpGaD
Ruxolitinib—JAK1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000198	0.000532	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 interactions—AKT1—thymus cancer	0.000198	0.000532	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—KIT—thymus cancer	0.000198	0.000532	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD8A—thymus cancer	0.000197	0.00053	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR—AKT1—thymus cancer	0.000196	0.000528	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CD4—thymus cancer	0.000194	0.000523	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000194	0.000523	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by PDGF—AKT1—thymus cancer	0.000193	0.000521	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000192	0.000518	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD8A—thymus cancer	0.000192	0.000518	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000192	0.000517	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MAML2—thymus cancer	0.000191	0.000514	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—KIT—thymus cancer	0.000189	0.000509	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000187	0.000502	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by NGF—AKT1—thymus cancer	0.000186	0.0005	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD8A—thymus cancer	0.000184	0.000496	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—AKT1—thymus cancer	0.000184	0.000495	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—IL2—thymus cancer	0.000183	0.000493	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000182	0.000491	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD8A—thymus cancer	0.000182	0.000489	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000181	0.000487	CbGpPWpGaD
Ruxolitinib—MAP3K7—TGF-beta Signaling Pathway—AKT1—thymus cancer	0.000179	0.000482	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CYLD—thymus cancer	0.000179	0.000482	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—KIT—thymus cancer	0.000178	0.000479	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CD4—thymus cancer	0.000176	0.000473	CbGpPWpGaD
Ruxolitinib—JAK1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000175	0.000472	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by SCF-KIT—AKT1—thymus cancer	0.000175	0.000471	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TP53—thymus cancer	0.000175	0.000471	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MAML2—thymus cancer	0.000173	0.000466	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000172	0.000463	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000171	0.00046	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000168	0.000451	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000166	0.000446	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	0.000166	0.000446	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB4—AKT1—thymus cancer	0.000165	0.000444	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MAML2—thymus cancer	0.000164	0.000442	CbGpPWpGaD
Ruxolitinib—JAK2—Factors involved in megakaryocyte development and platelet production—TP53—thymus cancer	0.000162	0.000435	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MAML2—thymus cancer	0.000162	0.000435	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—KIT—thymus cancer	0.000162	0.000435	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—KIT—thymus cancer	0.000161	0.000433	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signal transduction—AKT1—thymus cancer	0.000157	0.000424	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—IL2—thymus cancer	0.000157	0.000424	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR—AKT1—thymus cancer	0.000157	0.000422	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—AKT1—thymus cancer	0.000156	0.000421	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD8A—thymus cancer	0.000156	0.00042	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB2—AKT1—thymus cancer	0.000156	0.00042	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 signaling—AKT1—thymus cancer	0.000155	0.000418	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CD4—thymus cancer	0.000154	0.000415	CbGpPWpGaD
Ruxolitinib—MAP3K7—Insulin Signaling—AKT1—thymus cancer	0.000154	0.000413	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—KIT—thymus cancer	0.000153	0.000412	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—KIT—thymus cancer	0.000149	0.000402	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—KIT—thymus cancer	0.000149	0.0004	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000148	0.000399	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—KIT—thymus cancer	0.000148	0.000398	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—AKT1—thymus cancer	0.000148	0.000397	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000146	0.000393	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—AKT1—thymus cancer	0.000146	0.000393	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR in disease—AKT1—thymus cancer	0.000146	0.000393	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—AKT1—thymus cancer	0.000145	0.00039	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—KIT—thymus cancer	0.000145	0.000389	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—TP53—thymus cancer	0.000144	0.000388	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—KIT—thymus cancer	0.000144	0.000388	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000143	0.000386	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—AKT1—thymus cancer	0.000143	0.000384	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000142	0.000381	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000141	0.000381	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—TP53—thymus cancer	0.000139	0.000375	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—KIT—thymus cancer	0.000138	0.000373	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—IL2—thymus cancer	0.000137	0.000369	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—KIT—thymus cancer	0.000136	0.000367	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—AKT1—thymus cancer	0.000135	0.000363	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—TP53—thymus cancer	0.000134	0.000362	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL2—thymus cancer	0.000133	0.000358	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—AKT1—thymus cancer	0.000133	0.000357	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MAML2—thymus cancer	0.000131	0.000353	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—AKT1—thymus cancer	0.000131	0.000353	CbGpPWpGaD
Ruxolitinib—JAK2—BDNF signaling pathway—AKT1—thymus cancer	0.000131	0.000351	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000129	0.000348	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000127	0.000342	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL2—thymus cancer	0.000125	0.000337	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—AKT1—thymus cancer	0.000125	0.000336	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MAML2—thymus cancer	0.000125	0.000336	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL2—thymus cancer	0.000124	0.000335	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD4—thymus cancer	0.000124	0.000333	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MAML2—thymus cancer	0.000121	0.000326	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—AKT1—thymus cancer	0.000119	0.000321	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—AKT1—thymus cancer	0.000119	0.00032	CbGpPWpGaD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000119	0.00032	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD8A—thymus cancer	0.000119	0.00032	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—AKT1—thymus cancer	0.000118	0.000318	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MAML2—thymus cancer	0.000118	0.000317	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—AKT1—thymus cancer	0.000118	0.000317	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—AKT1—thymus cancer	0.000118	0.000316	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—TP53—thymus cancer	0.000117	0.000316	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—KIT—thymus cancer	0.000117	0.000316	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CD4—thymus cancer	0.000117	0.000315	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—IL2—thymus cancer	0.000116	0.000311	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD8A—thymus cancer	0.000115	0.00031	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CD4—thymus cancer	0.000114	0.000307	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CD4—thymus cancer	0.000114	0.000306	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL2—thymus cancer	0.000114	0.000306	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL2—thymus cancer	0.000113	0.000305	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD4—thymus cancer	0.000113	0.000305	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—KIT—thymus cancer	0.000113	0.000303	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD8A—thymus cancer	0.000112	0.000301	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—AKT1—thymus cancer	0.000111	0.000299	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—AKT1—thymus cancer	0.000111	0.000298	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000111	0.000298	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—AKT1—thymus cancer	0.000111	0.000298	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD4—thymus cancer	0.000111	0.000298	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CD4—thymus cancer	0.00011	0.000297	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—AKT1—thymus cancer	0.00011	0.000295	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000109	0.000293	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—KIT—thymus cancer	0.000108	0.000292	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—AKT1—thymus cancer	0.000108	0.000291	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD4—thymus cancer	0.000106	0.000285	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—AKT1—thymus cancer	0.000106	0.000285	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL2—thymus cancer	0.000105	0.000283	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—KIT—thymus cancer	0.000104	0.000281	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD4—thymus cancer	0.000104	0.000281	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL2—thymus cancer	0.000104	0.00028	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—AKT1—thymus cancer	0.000102	0.000276	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL2—thymus cancer	0.000102	0.000274	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—TP53—thymus cancer	0.000101	0.000272	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—IL2—thymus cancer	9.95e-05	0.000268	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—AKT1—thymus cancer	9.95e-05	0.000268	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—AKT1—thymus cancer	9.92e-05	0.000267	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	9.8e-05	0.000264	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—IL2—thymus cancer	9.78e-05	0.000263	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—AKT1—thymus cancer	9.69e-05	0.000261	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL2—thymus cancer	9.59e-05	0.000258	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—AKT1—thymus cancer	9.26e-05	0.000249	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAML2—thymus cancer	9.19e-05	0.000247	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL2—thymus cancer	9.03e-05	0.000243	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD4—thymus cancer	8.97e-05	0.000241	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—KIT—thymus cancer	8.92e-05	0.00024	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL2—thymus cancer	8.88e-05	0.000239	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Wnt—AKT1—thymus cancer	8.88e-05	0.000239	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—KIT—thymus cancer	8.81e-05	0.000237	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL2—thymus cancer	8.81e-05	0.000237	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—AKT1—thymus cancer	8.77e-05	0.000236	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD8A—thymus cancer	8.74e-05	0.000235	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—AKT1—thymus cancer	8.7e-05	0.000234	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—KIT—thymus cancer	8.66e-05	0.000233	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—AKT1—thymus cancer	8.63e-05	0.000232	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—thymus cancer	8.62e-05	0.000232	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—AKT1—thymus cancer	8.56e-05	0.00023	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TP53—thymus cancer	8.55e-05	0.00023	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—AKT1—thymus cancer	8.54e-05	0.00023	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—KIT—thymus cancer	8.4e-05	0.000226	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—thymus cancer	8.28e-05	0.000223	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL2—thymus cancer	8.25e-05	0.000222	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TP53—thymus cancer	8.04e-05	0.000216	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—KIT—thymus cancer	7.99e-05	0.000215	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—AKT1—thymus cancer	7.68e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—KIT—thymus cancer	7.58e-05	0.000204	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—AKT1—thymus cancer	7.54e-05	0.000203	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—KIT—thymus cancer	7.46e-05	0.000201	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—AKT1—thymus cancer	7.43e-05	0.0002	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—thymus cancer	7.35e-05	0.000198	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—AKT1—thymus cancer	7.34e-05	0.000198	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TP53—thymus cancer	7.27e-05	0.000196	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—AKT1—thymus cancer	7.22e-05	0.000194	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—thymus cancer	6.82e-05	0.000184	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—AKT1—thymus cancer	6.79e-05	0.000183	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—AKT1—thymus cancer	6.75e-05	0.000182	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—thymus cancer	6.67e-05	0.00018	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—thymus cancer	6.62e-05	0.000178	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—KIT—thymus cancer	6.56e-05	0.000177	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—AKT1—thymus cancer	6.42e-05	0.000173	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—thymus cancer	6.42e-05	0.000173	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—thymus cancer	6.28e-05	0.000169	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—AKT1—thymus cancer	6.27e-05	0.000169	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—thymus cancer	6.2e-05	0.000167	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—AKT1—thymus cancer	6.16e-05	0.000166	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—AKT1—thymus cancer	6.14e-05	0.000165	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—thymus cancer	6.11e-05	0.000165	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—thymus cancer	6.09e-05	0.000164	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—KIT—thymus cancer	6.06e-05	0.000163	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—thymus cancer	5.91e-05	0.000159	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—AKT1—thymus cancer	5.84e-05	0.000157	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—KIT—thymus cancer	5.77e-05	0.000155	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—AKT1—thymus cancer	5.69e-05	0.000153	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—AKT1—thymus cancer	5.69e-05	0.000153	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—AKT1—thymus cancer	5.67e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TP53—thymus cancer	5.65e-05	0.000152	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—AKT1—thymus cancer	5.65e-05	0.000152	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—KIT—thymus cancer	5.6e-05	0.000151	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—thymus cancer	5.57e-05	0.00015	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—AKT1—thymus cancer	5.52e-05	0.000148	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—AKT1—thymus cancer	5.5e-05	0.000148	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—KIT—thymus cancer	5.43e-05	0.000146	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AKT1—thymus cancer	5.39e-05	0.000145	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—thymus cancer	5.34e-05	0.000144	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AKT1—thymus cancer	5.31e-05	0.000143	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—AKT1—thymus cancer	5.28e-05	0.000142	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—thymus cancer	5.25e-05	0.000141	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—AKT1—thymus cancer	5.2e-05	0.00014	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—thymus cancer	5.05e-05	0.000136	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—thymus cancer	5.02e-05	0.000135	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AKT1—thymus cancer	4.9e-05	0.000132	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—AKT1—thymus cancer	4.87e-05	0.000131	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AKT1—thymus cancer	4.82e-05	0.00013	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—AKT1—thymus cancer	4.78e-05	0.000129	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—thymus cancer	4.72e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—thymus cancer	4.63e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—thymus cancer	4.62e-05	0.000124	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—AKT1—thymus cancer	4.48e-05	0.00012	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—AKT1—thymus cancer	4.3e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—KIT—thymus cancer	4.24e-05	0.000114	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—AKT1—thymus cancer	4.13e-05	0.000111	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—thymus cancer	4.06e-05	0.000109	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AKT1—thymus cancer	3.99e-05	0.000107	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—thymus cancer	3.98e-05	0.000107	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—thymus cancer	3.94e-05	0.000106	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—thymus cancer	3.82e-05	0.000103	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AKT1—thymus cancer	3.62e-05	9.73e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—thymus cancer	3.43e-05	9.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—AKT1—thymus cancer	3.4e-05	9.16e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—thymus cancer	3.37e-05	9.07e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AKT1—thymus cancer	3.36e-05	9.05e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—AKT1—thymus cancer	3.3e-05	8.89e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—AKT1—thymus cancer	3.2e-05	8.63e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—AKT1—thymus cancer	3.05e-05	8.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AKT1—thymus cancer	3.02e-05	8.12e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—thymus cancer	2.99e-05	8.04e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AKT1—thymus cancer	2.89e-05	7.79e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AKT1—thymus cancer	2.85e-05	7.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AKT1—thymus cancer	2.74e-05	7.38e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—thymus cancer	2.61e-05	7.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—thymus cancer	2.53e-05	6.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—AKT1—thymus cancer	2.5e-05	6.74e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—thymus cancer	2.45e-05	6.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—AKT1—thymus cancer	2.31e-05	6.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AKT1—thymus cancer	2.2e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AKT1—thymus cancer	2.14e-05	5.75e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AKT1—thymus cancer	2.07e-05	5.58e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—thymus cancer	1.92e-05	5.16e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AKT1—thymus cancer	1.62e-05	4.36e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AKT1—thymus cancer	5.47e-06	1.47e-05	CbGpPWpGaD
